CAS: 51957-32-5; 4-Chloro-5-Methylpyrimidine

该化合物是一种环状的七环有机化合物,其特征为一个有六人组成的芳香环,其中含有1号站点和3号站点的两个氮原子;4号站点存在氯原子,5号站点存在一个甲基组,该化合物的区别在于该化合物.该化合物一般是无色的,视温度和纯度而定,可变成黄色的黄色液体或固体;该化合物以其在有机合成中的作用而著称,特别是在制药业,该化合物是生产各种生物活性化合物的中间体;该化合物在极地有机溶剂中具有中度溶性,而且具有相对较低的沸点;安全数据表明,由于潜在的毒性和刺激性,应当谨慎处理该物质;与许多卤化化合物一样,它也可能造成环境关切,需要适当的处置方法.

结构式图片

相似化合物

4316-97-6 1780-31-0 16357-68-9

欧盟法规

C&L通报

上下游产品

CAS号17758-52-0 5-甲基嘧啶-4-醇 | CAS号4595-61-3 嘧啶-5-羧酸 | CAS号3096-47-7 9H-Fluoren-9-on... | CAS号87999-62-0 5-methyl-4-(5-m... | CAS号87999-60-8 [5-chloro-2-(5-... | CAS号87999-61-9 2,2'-Bis(o-chlo... | CAS号2036-41-1 5-甲基嘧啶 | CAS号69142-10-5 4(1H)-Pyrimidin...

合成工艺路线路线简述

    📜5-甲基嘧啶-4-醇置于三氯氧磷体系中,化学反应生成 4-氯-5-甲基嘧啶
    参考文献:Vanderhaeghe; Claesen,Bulletin Des Societes Chimiques Belges,1957,Vol. 66,P. 276,289
    标题:Vanderhaeghe; Claesen,Bulletin Des Societes Chimiques Belges,1957,Vol. 66,P. 276,289

    专利信息


    专利号:US-2002040032-A1
    优先权日:2000-07-07
    标 题:Methods for stimulation of synthesis of synaptophysin in the central nervous system
    发明人:GLASKY MICHELLE S; LAHIRI DEBOMOY K; FARLOW MARTIN R
    摘要:A method of increasing the synthesis and/or secretion of synaptophysin comprises administering to a patient with a neurological disease or a patient at risk of developing a neurological disease an effective quantity of a purine derivative or analogue, a tetrahydroindolone derivative or analogue, or a pyrimidine derivative or analogue. If the compound is a purine derivative, the purine moiety can be guanine or hypoxanthine. The neurological disease can be a neurodegenerative disease such as Alzheimer's disease or a neurodevelopmental disorder such as Down's syndrome. Typically, the compound can pass through the blood-brain barrier. The purine moiety can be hypoxanthine or guanine. A particularly preferred purine derivative is N-4-carboxyphenyl-3-(6-oxohydropurin-9-yl) propanamide.

    专利号:US-8853410-B2
    优先权日:2009-04-30
    标 题:Process for preparing substituted isoxazoline compounds and their precursors
    发明人:RACK MICHAEL; KOERBER KARSTEN; KAISER FLORIAN
    权利人:RACK MICHAEL; KOERBER KARSTEN; KAISER FLORIAN; BASF SE
    摘要:The present invention relates to a new method of preparing halogenated styrene compounds of formula (VIII) n nwhich are precursors in the process of synthesis of substituted isoxazoline compounds of formula (I)n n nwherein R 1 to R 5 , R 8 and R 9 are described as in the description.n n The present invention relates further to the synthesis of compounds of formula (I) starting from acetophenones. The desired styrenes of formula are prepared from the appropriate substituted acetophenone. Asides bromo anilines react with formoxime. Obtained oximes undergo a cycloaddition with the styrenes and give isoxazolines. Compounds of formula (I) can then be prepared in a palladium catalyzed carbonylative amination reaction of the isoxazolines.

    专利号:US-2004116453-A1
    优先权日:2001-07-17
    标 题 :Synthesis and methods of use pyrimidine analogues and derivatives
    发明人:FICK DAVID B; FOREMAN MARK M; GLASKY ALVIN J
    摘要:A pyrimidine derivative or analogue comprises an amino-substituted six-membered heterocyclic moiety, moiety A, linked through a linker L to a moiety B, where B is a carboxylic acid, a carboxylic acid ester, or a moiety of the structure N(Y 1 )-D, where Y 1 can be one of a variety of substituents, including hydrogen or alkyl, and D is a moiety that enhances the pharmacological effects, promotes absorption, or promotes blood-brain barrier penetration of the derivative or analogue. The moiety A can have two or three nitrogen atoms in the ring; typically, the moiety A is a pyrimidine moiety, with two nitrogen atoms in the ring. The moiety B can be one of a variety of moieties, including moieties having nootropic activity or other biological or physiological activity.

    专利号:US-8362019-B2
    优先权日:2008-02-01
    标 题:Synthesis and anti-proliferative effect of substituted imidazo[4,5-b]pyrazine compounds
    发明人:WINFIELD LEYTE L
    权利人:SPELMAN COLLEGE; WINFIELD LEYTE L
    摘要:This invention provides for compounds, compositions, and methods that involve anti-proliferative and anti-neoplastic activity in cancer cells. In particular, a series of benzimidazole, purine, imidazopyridine, and imidazopyrizine compounds having selected substitution patterns are disclosed, and the activity of various subject compounds is demonstrated. In particular, the disclosure provides for substituted imidazo[4,5-b]pyrazine compounds having the general formula n ntheir salts, pharmaceutical compositions, and methods of treatment using the subject compounds and compositions.

    专利号:CN-109096181-B
    优先权日:2018-09-29
    标题:A method for ultrasonic-assisted green synthesis of 2-sulfonylpyridine derivatives

    专利号:US-8841306-B2
    优先权日:2008-11-20
    标 题:Antimicrobials
    发明人:JAIN RAJESH; TREHAN SANJAY; DAS JAGATTARAN; KANWAR SANDEEP; MAGADI SITARAM KUMAR; SHARMA SUDHIR KUMAR
    权利人:JAIN RAJESH; TREHAN SANJAY; DAS JAGATTARAN; KANWAR SANDEEP; MAGADI SITARAM KUMAR; SHARMA SUDHIR KUMAR; PANACEA BIOTEC LTD
    摘要:The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella , acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 420.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知